FDA Approved: IRBESARTAN — Supplemental Application (Solco Healthcare U.S., LLC)

View source ↗

Summary

FDA approved Solco Healthcare U.S., LLC's supplemental application for IRBESARTAN, authorizing the generic product's marketing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy in Type 2 Diabetes Mellitus
• Hypertension

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)